| Literature DB >> 35760872 |
Satoru Sugimoto1, Hebe Agustina Mena2, Brian E Sansbury2, Shio Kobayashi3, Tadataka Tsuji1, Chih-Hao Wang1, Xuanzhi Yin2, Tian Lian Huang1, Joji Kusuyama1, Sean D Kodani1, Justin Darcy1, Gerson Profeta1, Nayara Pereira4, Rudolph E Tanzi5, Can Zhang5, Thomas Serwold3, Efi Kokkotou6, Laurie J Goodyear1, Aaron M Cypess7, Luiz Osório Leiria1,4, Matthew Spite8, Yu-Hua Tseng9,10.
Abstract
Obesity induces chronic inflammation resulting in insulin resistance and metabolic disorders. Cold exposure can improve insulin sensitivity in humans and rodents, but the mechanisms have not been fully elucidated. Here, we find that cold resolves obesity-induced inflammation and insulin resistance and improves glucose tolerance in diet-induced obese mice. The beneficial effects of cold exposure on improving obesity-induced inflammation and insulin resistance depend on brown adipose tissue (BAT) and liver. Using targeted liquid chromatography with tandem mass spectrometry, we discovered that cold and β3-adrenergic stimulation promote BAT to produce maresin 2 (MaR2), a member of the specialized pro-resolving mediators of bioactive lipids that play a role in the resolution of inflammation. Notably, MaR2 reduces inflammation in obesity in part by targeting macrophages in the liver. Thus, BAT-derived MaR2 could contribute to the beneficial effects of BAT activation in resolving obesity-induced inflammation and may inform therapeutic approaches to combat obesity and its complications.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35760872 DOI: 10.1038/s42255-022-00590-0
Source DB: PubMed Journal: Nat Metab ISSN: 2522-5812